A recent study has found a “new biomaterial that can be injected intravenously, reduces inflammation in tissue and promotes cell and tissue repair.” It has been tested and proven to be effective in “treating tissue damage caused by heart attacks in both rodent and large animal models” and researchers believe that the biomaterial “could be beneficial to patients with traumatic brain injury and pulmonary arterial hypertension.” Karen Christman, professor and lead researcher on the team developing the material, shared that a study on the safety and efficacy of the material for humans will begin in 1-2 years.